Abbvie Inc. (ABBV) SEC Filings — 2025
20 SEC filings for Abbvie Inc. (ABBV) in 2025.
Filings
- AbbVie's Q3 Earnings Plummet 88% Amidst Aggressive R&D Investments — 10-Q · Nov 4, 2025
- AbbVie Inc. Files 8-K on Financials — 8-K · Oct 31, 2025
- AbbVie Inc. Files 8-K on Financials and Debt — 8-K · Oct 3, 2025
- AbbVie Inc. Files 8-K Report — 8-K · Sep 11, 2025
- AbbVie Q2 Earnings Dip Amid Revenue Decline, Legal Headwinds — 10-Q · Aug 4, 2025
- AbbVie Inc. Files 8-K on Financial Operations — 8-K · Jul 31, 2025
- AbbVie Inc. Files 8-K on Financials and Senior Notes — 8-K · Jul 3, 2025
- AbbVie Inc. Files 8-K: Director Changes and Shareholder Votes — 8-K · May 13, 2025
- Abbvie Inc. 10-Q Filing — 10-Q · May 9, 2025
- AbbVie Inc. Files 8-K on Financials — 8-K · Apr 25, 2025
- AbbVie Inc. Files 8-K on Financial Operations — 8-K · Apr 3, 2025
- AbbVie Inc. DEF 14A: Executive Compensation Details — DEF 14A · Mar 24, 2025
- AbbVie Inc. Files 8-K Report — 8-K · Feb 26, 2025
- AbbVie Inc. Files 8-K: Senior Notes and Stock Details — 8-K · Feb 19, 2025
- AbbVie Inc. Files 8-K on Officer Changes and Financials — 8-K · Feb 14, 2025
- AbbVie Files 2024 10-K — 10-K · Feb 14, 2025
- AbbVie Inc. Files 8-K Report — 8-K · Feb 5, 2025
- AbbVie Inc. Files 8-K on Financials and Debt — 8-K · Jan 31, 2025
- AbbVie Inc. Discloses Material Impairment — 8-K · Jan 10, 2025
- AbbVie Inc. Files 8-K on Financial Operations — 8-K · Jan 6, 2025